Reynders McVeigh Capital Management’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-286
| Closed | -$251K | – | 204 |
|
|
2023
Q4 | $251K | Hold |
286
| – | – | 0.02% | 176 |
|
|
2023
Q3 | $235K | Buy |
286
+5
| +2% | +$4.11K | 0.02% | 180 |
|
|
2023
Q2 | $202K | Sell |
281
-1
| -0.4% | -$719 | 0.01% | 199 |
|
|
2023
Q1 | $232K | Hold |
282
| – | – | 0.02% | 188 |
|
|
2022
Q4 | $203K | Sell |
282
-387
| -58% | -$279K | 0.01% | 207 |
|
|
2022
Q3 | $461K | Hold |
669
| – | – | 0.04% | 145 |
|
|
2022
Q2 | $395K | Sell |
669
-7
| -1% | -$4.13K | 0.03% | 164 |
|
|
2022
Q1 | $472K | Sell |
676
-25
| -4% | -$17.5K | 0.03% | 164 |
|
|
2021
Q4 | $443K | Sell |
701
-238
| -25% | -$150K | 0.03% | 169 |
|
|
2021
Q3 | $568K | Sell |
939
-323
| -26% | -$195K | 0.03% | 143 |
|
|
2021
Q2 | $705K | Sell |
1,262
-127
| -9% | -$70.9K | 0.04% | 127 |
|
|
2021
Q1 | $657K | Sell |
1,389
-174
| -11% | -$82.3K | 0.04% | 136 |
|
|
2020
Q4 | $755K | Sell |
1,563
-154
| -9% | -$74.4K | 0.05% | 123 |
|
|
2020
Q3 | $961K | Sell |
1,717
-80
| -4% | -$44.8K | 0.07% | 100 |
|
|
2020
Q2 | $1.12M | Sell |
1,797
-45
| -2% | -$28.1K | 0.1% | 94 |
|
|
2020
Q1 | $899K | Buy |
1,842
+7
| +0.4% | +$3.42K | 0.1% | 96 |
|
|
2019
Q4 | $689K | Hold |
1,835
| – | – | 0.07% | 133 |
|
|
2019
Q3 | $509K | Hold |
1,835
| – | – | 0.05% | 141 |
|
|
2019
Q2 | $574K | Hold |
1,835
| – | – | 0.06% | 134 |
|
|
2019
Q1 | $753K | Buy |
1,835
+500
| +37% | +$205K | 0.08% | 118 |
|
|
2018
Q4 | $499K | Buy |
+1,335
| New | +$499K | 0.07% | 127 |
|